Product
Mass spectrometry
1 clinical trial
1 indication
Indication
ATRTClinical trial
Heterogeneity in Rhabdoid Tumors : Proteomic and Single-Cell Analyses to Identify New Therapeutic TargetsStatus: Completed, Estimated PCD: 2023-02-17
1 clinical trial
1 indication